Compound CAR T-Cells as a Double-Pronged Approach for Treating Acute Myeloid Leukemia

Leukemia - United Kingdom
doi 10.1038/s41375-018-0075-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

CAR-T Cells Targeting CLL-1 as an Approach to Treat Acute Myeloid Leukemia

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2018English

CAR T Cells for Acute Lymphoblastic Leukemia

American Journal of Hematology
Hematology
2019English

Clinical Trials of Dual-Target CAR T Cells, Donor-Derived CAR T Cells, and Universal CAR T Cells for Acute Lymphoid Leukemia

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2019English

Challenges in Treating Older Patients With Acute Myeloid Leukemia

Journal of Oncology
Oncology
2010English

Indoleamine 2,3-Dioxygenase and Regulatory T Cells in Acute Myeloid Leukemia

Hematology
Hematology
2016English

CAR-T Cells: An Innovative Therapeutic Strategy Against Pediatric Acute Lymphoblastic Leukemia

Research in Molecular Medicine (RMM)
2019English

“Epigenetic” Modification as Therapy for Acute Myeloid Leukemia

Cancer
Cancer ResearchOncology
2017English

T(3;4)(p21;q34) as a Sole Anomaly in Acute Myeloid Leukemia Patient

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Acute Myeloid Leukemia

JAMA - Journal of the American Medical Association
Medicine
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy